D-0315-2026 Class II Ongoing
FDA drug recall D-0315-2026 was initiated by F.H. INVESTMENTS, Inc. (Dba Asteria Health) on Jan 26, 2026 and is designated Class II. Reason for recall: Presence of Foreign substance - potential presence of metal particulate matter The recall status is ongoing. Affected quantity: 715 pellets.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 18, 2026
- Initiation Date
- Jan 26, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 715 pellets
Product description
ESTRADIOL, 37.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3037-32.
Reason for recall
Presence of Foreign substance - potential presence of metal particulate matter
Distribution pattern
Nationwide in the USA
Code information
Lot#: 253000125, Exp. 06/09/2026.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0315-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026